RE:RE:RE:RE:RE:RE:RE:The Big IFA couple of reasons for being hesitant look at the example below which investors pickup on. Nearing to completion to 9 months later kicking the can down the road, Eugene describing it as rapid progress.
Don't need the Nasdaq need credibility with credible news. Eugene, Elliott the consultant and the Boston group?
For the three months ended Sep 30,2021
"Development of assays to measure drug levels in both nonhuman primate and human studies have been initiated and are nearing completion."
For the year ended Dec 31, 20121
"Development of assays to measure drug levels in both nonhuman primate and human studies have been initiated and are expected to complete development in the second quarter of 2022"
For the three months ended Mar 31,2021
"Development of assays to measure drug levels in nonhuman primates was completed in the second quarter and development of assays to measure drug levels in human studies are expected to be completed in the third quarter of 2022"